Definitive Healthcare (DH) EBITDA (2020 - 2026)

Definitive Healthcare has reported EBITDA for 7 years, with the latest figure at -$201.3 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 8.93% year-over-year to -$201.3 million; the trailing twelve-month figure through Mar 2026 stood at -$60.4 million (up 93.13% YoY), and the FY2025 full-year result was -$43.9 million, up 93.82% from the prior year.
• EBITDA for Q1 2026 stood at -$201.3 million, down from $153.7 million in the prior quarter.
• The five-year high for EBITDA was $153.7 million in Q4 2025, with the low at -$369.6 million in Q2 2024.
• Historically, EBITDA has averaged -$78.2 million across 5 years, with a median of -$12.1 million in 2023.
• Annual changes were most pronounced in 2024 — EBITDA slumped 2962.22% — and 2025, when it soared 254.38%.
• Definitive Healthcare's EBITDA stood at -$10.5 million in 2022, then rose by 4.34% to -$10.1 million in 2023, then sank by 887.73% to -$99.6 million in 2024, then soared by 254.38% to $153.7 million in 2025, then sank by 230.96% to -$201.3 million in 2026.
• The last three EBITDA figures came in at -$201.3 million (Q1 2026), $153.7 million (Q4 2025), and -$8.7 million (Q3 2025), per Business Quant data.